Dr Reddy's acquires Dow's molecule biz

April 2008
Chemical Business;Apr2008, Vol. 22 Issue 4, p86
Trade Publication
The article focuses on a definitive agreement entered into by Dr. Reddy's Laboratories Ltd. with the Dow Chemical Co. to acquire a portion of Dowpharma Small Molecules business associated with its sites in Mirfield and Cambridge, England. The acquisition will include the relevant business, intellectual property as well as the transfer of the facilities at such British sites. Dr. Reddy's vice chairman and chief executive officer (CEO) G. V. Prasad cited the advantage of the deal to his company.


Related Articles

  • A Prescription for Change. Kumar Sharma, E. // Business Today;12/2/2007, Vol. 16 Issue 24, p194 

    The article presents information on recent developments associated with Indian business enterprise DR Reddy's Laboratories. Recently DR Reddy's has acquired two companies including one in Mexico and another in Germany. G.V. Prasad, Vice-Chairman, the chief executive officer (CEO) of Dr Reddy's...

  • Reddy-ly establishing a European presence.  // Pharmaceutical Technology Europe;May2008, Vol. 20 Issue 5, p9 

    The article focuses on the significance of the two European acquisitions of Dr. Reddy's Laboratories Ltd. to its generic pipeline and research and development (R&D) infrastructure. The author claims that the acquisitions could result in cheaper medicines produced by the pharmaceutical company....

  • Dr. Reddy's to Buy Part of Dow's Pharma Business in the U.K. Ramesh, Deepti // Chemical Week;4/7/2008, Vol. 170 Issue 11, p15 

    The article reports on an agreement entered by pharmaceutical company Dr. Reddy's Laboratories with Dow Chemical to acquire a part of the Dowpharma Small Molecules business at its sites in Mirfield and Cambridge, England. The firms now await regulatory approval for the deal which is expected to...

  • April March. Sharma, E. Kumar // Business Today;6/1/2008, Vol. 17 Issue 11, p38 

    The article reports on the acquisitions made by Dr Reddy's Laboratories in April 2008. Dr Reddy's Laboratories announced its decision to acquire a portion of Dowpharma Small Molecules Business from Dow Chemical Co. in April 1, 2008. Two days later, the company revealed its takeover of Jet...

  • Effortless navigator.  // Business Today;12/21/2014, Vol. 23 Issue 25, p1 

    The article features the G.V. Prasad, Co-Chairman and Chief Executive Officer of the Dr. Reddy's Laboratories, who is a passionate wildlife and nature photographer. The main strategy that helps him to run his business and engage with people is by viewing the world through camera lenses.

  • G.V. Prasad is Chairman & CEO of Dr Reddy's.  // Chemical Business;Apr2013, Vol. 27 Issue 4, p63 

    This article announces the appointment of G. V. Prasad as chairman and chief executive officer (CEO) of pharmaceutical company Dr. Reddy's Laboratories Ltd.

  • Dr. Reddy's Wins Award.  // Chain Drug Review;2/22/2016, Vol. 38 Issue 4, p57 

    The article reports that pharmaceutical company Dr. Reddy's has been named the best governed company for 2015 at the third annual Asia Business Responsibility Summit, with chairman G.V. Prasad accepting the award.

  • Dr Reddy's net rises 32%.  // Chemical Business;Nov2010, Vol. 24 Issue 11, p63 

    The article reports on the 31.9% increase in the net profit of Dr. Reddy's Laboratories (DRL) for the quarter ended September 30, 2010. The pharmaceutical company's net profit surged from 217.3 crore in 2009 to 286.7 crore in 2010 while its revenues went up by 2% from 1,836.8 crore in 2009 to...

  • World Briefs.  // Pharmaceutical Technology;Jun2008, Vol. 32 Issue 6, p22 

    The article offers world new briefs related to acquisition. Dr. Reddy's Laboratories Ltd. acquired Dow Chemical Co.'s Downpharma small molecules business and BASF AG's manufacturing facility. DSM Corp. agreed to acquire the Polymer Technology Group Inc. and is subject to regulate approval, which...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics